Company Badge
USPTO Data Jan 1 1976 - Oct 20 2026
8 Patents
#344 in Austin, TX
#2,280 in Texas
#35,941 in US
Rules-Based Medicine, Inc.
Forward Citations = 6
9 inventors:
Austin, TX, United States of America
Rules-Based Medicine, Inc.
% Expired Patents = 12.5
EPO Patents = 1
Trademarks = 5
Forward Citations = 6
Loading Chart...
Loading Chart...
9 inventors (with patents filed for the assignee):
Andrew Raymon Morton Bradbury (7 out of 9 patents)
Andre Teixeira (7 out of 9 patents)
Michael Frank Erasmus (5 out of 9 patents)
4. Samuel T Labrie (1 out of 1 patent)
5. Ralph L McDade (1 out of 4 patents)
6. Dominic Eisinger (1 out of 2 patents)
7. Karri L Ballard (1 out of 1 patent)
8. Michael D Spain (1 out of 4 patents)
9. James P Mapes (1 out of 3 patents)
10. Manfred Schmolz (3 patents)
8 patents:
2. 12359346 - Antibody libraries with maximized antibody developability characteristics (2025-07-15),
4. 12351946 - Antibody libraries with maximized antibody developability characteristics (2025-07-08),
5. 12351945 - Antibody libraries with maximized antibody developability characteristics (2025-07-08),
6. 12344959 - Antibody libraries with maximized antibody developability characteristics (2025-07-01),
Company Overview
Rules-based Medicine, Inc. is a biotechnology company specializing in the development of innovative diagnostic solutions. The company focuses on creating multiplexed assays that enable the simultaneous measurement of multiple biomarkers, facilitating personalized medicine and improving patient outcomes. With a commitment to advancing healthcare through technology, Rules-based Medicine aims to provide healthcare professionals with the tools necessary for better diagnosis and treatment decisions.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Rules-Based Medicine, Inc.. Retrieved from https://idiyas.com/company/rules-based-medicine
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
1 patent (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]